Please use this identifier to cite or link to this item:
http://archive.cmb.ac.lk:8080/xmlui/handle/70130/6293
Title: | Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma |
Authors: | Jayaweera, Shansa Pranami E. Kanakanamge, Sacheela Prasadi Wanigasinghe Rajalingam, Dharshika Silva, Gayathri N. |
Keywords: | multiple myeloma proteasome inhibitors carfilzomib anti-tumor effect combination therapy |
Issue Date: | 2021 |
Publisher: | Frontiers in Oncology |
Citation: | Jayaweera SPE, Wanigasinghe Kanakanamge SP, Rajalingam D and Silva GN (2021) Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma. Front. Oncol. 11:740796. doi: 10.3389/fonc.2021.740796 |
Abstract: | The proteasome is crucial for the degradation of intracellular proteins and plays an important role in mediating a number of cell survival and progression events by controlling the levels of key regulatory proteins such as cyclins and caspases in both normal and tumor cells. However, compared to normal cells, cancer cells are more dependent on the ubiquitin proteasome pathway (UPP) due to the accumulation of proteins in response to uncontrolled gene transcription, allowing proteasome to become a potent therapeutic target for human cancers such as multiple myeloma (MM). Up to date, three proteasome inhibitors namely bortezomib (2003), carfilzomib (2012) and ixazomib (2015) have been approved by the US Food and Drug Administration (FDA) for the treatment of patients with relapsed and/or refractory MM. This review mainly focuses on the biochemical properties, mechanism of action, toxicity profile and pivotal clinical trials related to carfilzomib, a second-generation proteasome inhibitor that binds irreversibly with proteasome to overcome the major toxicities and resistance associated with bortezomib. |
URI: | https://www.frontiersin.org/articles/10.3389/fonc.2021.740796/full http://archive.cmb.ac.lk:8080/xmlui/handle/70130/6293 |
Appears in Collections: | Department of Chemistry |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fonc-11-740796.pdf | 1.75 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.